Listed

Standard Biotools Inc.: Form 10-Q for the period ended Jun 30, 2019

Filed with the SEC on Aug 7, 2019 and accepted by EDGAR at Aug 7, 2019, 17:18 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2019-06-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2019-04-01 to 2019-06-30$28.2mus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Revenue6 months2019-01-01 to 2019-06-30$58.3mus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Cost of revenue3 months2019-04-01 to 2019-06-30$12.8mus-gaap:CostOfGoodsAndServicesSold
Cost of revenue6 months2019-01-01 to 2019-06-30$26.0mus-gaap:CostOfGoodsAndServicesSold
Gross profit3 months2019-04-01 to 2019-06-30$15.4mus-gaap:GrossProfit
Gross profit6 months2019-01-01 to 2019-06-30$32.4mus-gaap:GrossProfit
Research and development3 months2019-04-01 to 2019-06-30$7.9mus-gaap:ResearchAndDevelopmentExpense
Research and development6 months2019-01-01 to 2019-06-30$16.2mus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative3 months2019-04-01 to 2019-06-30$22.1mus-gaap:SellingGeneralAndAdministrativeExpense
Selling, general and administrative6 months2019-01-01 to 2019-06-30$45.0mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2019-04-01 to 2019-06-30−$14.6mus-gaap:OperatingIncomeLoss
Operating income6 months2019-01-01 to 2019-06-30−$28.8mus-gaap:OperatingIncomeLoss
Interest expense3 months2019-04-01 to 2019-06-30$491.0kus-gaap:InterestExpense
Interest expense6 months2019-01-01 to 2019-06-30$3.2mus-gaap:InterestExpense
Income tax3 months2019-04-01 to 2019-06-30−$1.1mus-gaap:IncomeTaxExpenseBenefit
Income tax6 months2019-01-01 to 2019-06-30−$1.1mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2019-04-01 to 2019-06-30−$13.8mus-gaap:NetIncomeLoss
Net income6 months2019-01-01 to 2019-06-30−$39.2mus-gaap:NetIncomeLoss
Diluted EPS3 months2019-04-01 to 2019-06-30−$0.20us-gaap:EarningsPerShareBasicAndDiluted
Diluted EPS6 months2019-01-01 to 2019-06-30−$0.61us-gaap:EarningsPerShareBasicAndDiluted
Operating cash flow6 months2019-01-01 to 2019-06-30−$25.1mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure6 months2019-01-01 to 2019-06-30$685.0kus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2019-06-30$24.0mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2019-06-30$106.8mus-gaap:AssetsCurrent
Total assetsAt period end2019-06-30$283.8mus-gaap:Assets
Current liabilitiesAt period end2019-06-30$37.3mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2019-06-30$111.2mus-gaap:Liabilities
Shareholders' equityAt period end2019-06-30$172.6mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001162194-19-000068. Last ingested by Listed: Nov 5, 2026, 21:16 ET. Listed shows no prices and gives no investment advice.